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Abstract
Murid herpesvirus-4 (MuHV-4) provides a tractable model with which to define common, conserved features of gamma-
herpesvirus biology. The multi-membrane spanning glycoprotein M (gM) is one of only 4 glycoproteins that are essential for
MuHV-4 lytic replication. gM binds to gN and is thought to function mainly secondary envelopment and virion egress, for
which several predicted trafficking motifs in its C-terminal cytoplasmic tail could be important. We tested the contribution
of the gM cytoplasmic tail to MuHV-4 lytic replication by making recombinant viruses with varying C-terminal deletions.
Removing an acidic cluster and a distal YXXW motif altered the capsid distribution somewhat in infected cells but had little
effect on virus replication, either in vitro or in vivo. In contrast, removing a proximal YXXW motif as well completely
prevented productive replication. gM was still expressed, but unlike its longer forms showed only limited colocalization with
co-transfected gN, and in the context of whole virus appeared to support gN expression less well. We conclude that some
elements of the gM cytoplasmic tail are dispensible for MuHV-4 replication, but the tail as a whole is not.
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Introduction
Herpesviruses lytic gene functions have been studied mainly
with neurotropic alpha-herpesviruses. Relatively little is known
about the lytic replication of lymphotropic gamma-herpesviruses.
This reflects that Epstein-Barr virus (EBV) and the Kaposi’s
Sarcoma-associated Herpesvirus (KSHV) - the two known human
gamma-herpesviruses - are difficult to propagate lytically in vitro
and have narrow species tropisms that largely preclude their
analysis in vivo. However, the gamma-herpesviruses of other
animals offer tractable approaches to what are fundamentally the
same biological questions: how are new virions formed and how do
they spread.
A well-established small animal model of gamma-herpesvirus
infection is provided by Murid Herpesvirus-4 (MuHV-4), a
rhadinovirus closely related to KSHV [1,2]. MuHV-4 is B cell
tropic like EBV and KSHV [3], but also propagates lytically in a
range of fibroblast and epithelial lines. The main natural host for
MuHV-4 is yellow-necked mice [4]. It appears to have quite a
broad tropism [1] and also behaves much like a natural pathogen
in inbred laboratory mouse strains [5,6]. Thus, intranasal infection
causes an infectious mononucleosis-like illness followed by
asymptomatic viral persistence [7]; and immune suppression
causes disease [8]. Some 90% of MuHV-4 genes have obvious
equivalents in KSHV and EBV [9]. This is particularly true of
lytic genes; latency-associated genes are less well conserved.
MuHV-4 is therefore perhaps best suited to analyzing gamma-
herpesvirus lytic functions. Our interest is in the virion
glycoproteins. The complement of essential MuHV-4 glycopro-
teins is surprisingly small: only gH, gB, gN and gM [10–12] are
essential; gp70 [13,14], gp48 [15], ORF28 [16], ORF58 [17], gL
[18], gp150 [19] and ORF74 [20,21] are not.
gM is among the most conserved of all herpesvirus glycopro-
teins. It has 8 transmembrane domains without a large
extracellular domain, forms a disulfide-linked complex with gN
[12,22–24], and functions mainly in virion assembly and egress
[25–27]. Consistent with this role, co-transfected gM and gN co-
localize in the trans-Golgi network [12,23,28] where herpesvirus
secondary envelopment occurs [29]. The gM cytoplasmic tail
contains several trafficking motifs whose conservation in alpha-,
beta- and gamma-herpesviruses suggests that they have important
functions. These include YxxW motifs [30] which have been linked
to AP2 binding [31], and an acidic cluster which may be involved
in trans-Golgi targetting [32].
Herpesviruses vary surprisingly widely in their requirement for
gM [33–36]. In order to understand better the function of the
MuHV-4 gM, we have addressed specifically the role of its
cytoplasmic tail by generating recombinant viruses with cytoplas-
mic tail deletions. The distal cytoplasmic tail, including 2
conserved trafficking motifs, was dispensible for lytic replication,
both in vitro and in vivo. Yet the tail as a whole was not. Thus, the
gM transmembrane domains alone were insufficient to support
MuHV-4 replication.
PLoS ONE | www.plosone.org 1 May 2008 | Volume 3 | Issue 5 | e2131Figure 1. Generation of MuHV-4 gM cytoplasmic tail truncation mutants. A. The MuHV-4 gM cytoplasmic tail contains 2 YxxW motifs and an
acidic cluster. Truncation mutants were designed to delete sequentially each motif, as well as a further deletion of the amino acid residues between
the 2 YxxW motifs. Each gM derivative was tagged with eGFP to allow its visualization in infected cells. B. Because the truncations were too small to
be distinguished by Southern blotting, we checked them by PCR, using a 59 gM primer just upstream of the deletions (genomic co-ordinates 55944–
55962) and a 39 eGFP primer 65 nt from its start of codon. WT=wild-type, which does not amplify because it has no eGFP tag on gM. FL=full-length
tagged gM. T1.1 and T1.2 are independent mutants. The correctness of each deletion was confirmed by DNA sequencing its PCR product. C. The
MuHV-4 gM locus was modified by inserting a C-terminal eGFP tag. On this scale, the truncations of each mutant are too small to discern.
Independent FL T2, T3 and T4 mutants were made with an inserted oligonucleotide terminating translation before the eGFP tag. D. Viral DNA from
wild-type MuHV-4 (WT) or eGFP-tagged gM derivatives (FL, T2, T3, T4) was digested with BamHI, electrophoresed, blotted and probed with the Bam-B
genomic fragment as shown in C. Inserting the eGFP coding sequence with its 59 BamHI site converted a 10 kb band to 4.1 kb+6.6 kb (eGFP
contributing 0.7 kb). The T1 mutant was not included in this blot because it did not reconstitute infectious virus. E. DNA was recovered from each
untagged gM mutant virus. The oligonucleotide separating gM from the eGFP tag has a diagnostic EcoRI restriction site. The viral DNA was digested
with EcoRI and probed across the BamHI-B region as before. Oligonucleotide insertion converted a 9.2 kb EcoRI-restricted band to 5.5 kb+4.4 kb. The
difference in migration between the FL and T2–T4 viruses reflects a difference in DNA preparation rather than a real difference in size, since slightly
slower migration was observed for all the FL bands on ethidium bromide staining (data not shown). The small EcoRI bands at genomic co-ordinates
50,000–52,000 are not visible on this gel. BAC DNA from the T1.1 and T1.2 independent mutants was analyzed at the same time by BamHI digestion
and BamHI-B probing. Rev1 and Rev2 are revertant BACs for each mutant.
doi:10.1371/journal.pone.0002131.g001
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Mice
Female C57BL/6 mice were purchased from Harlan U.K. Ltd.
(Bicester, U.K.), housed in the Cambridge University Department
of Pathology, and infected intranasally with MuHV-4 (10
4 p.f.u.)
when 6–8 weeks old. Animal welfare conformed to the UK Animal
Health Act of 1981 (and subsequent amendments). All animal
experiments were performed under and in accordance with Home
Office Project Licence 80/1992.
Cell lines
BHK-21 fibroblasts, 293T cells, NIH-3T3-fibroblasts, the cre
recombinase-expressing derivative 3T3-CRE [37], and murine
embryonic fibroblasts (MEFs) were grown in Dulbecco’s modified
Eagle medium (Invitrogen, Paisley, U.K.) supplemented with
2 mM glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin
and 10% fetal calf serum (PAA laboratories, Linz, Austria).
Medium for MEFs was further supplemented with 50 mM2 -
mercaptoethanol. Cells were transfected where indicated using
Fugene-6 (Roche Diagnostics, Ltd., Lewes, U.K.).
Viral mutagenesis
The gM coding sequence without its stop codon (genomic co-
ordinates 56950–55796, 383 amino acids) [9] was cloned as a
BamHI/XhoI-restricted PCR product into the BamHI/XhoIs i t e so f
pEGFP-N3 (Clontech, Palo Alto, CA). Genomic co-ordinates
55800–54649 were then cloned into the AflII/NotI sites of the same
vector to provide a second recombination flank. Variants of this full-
length form (383 amino acid residues) were generated by shifting the
BamHI-restricted PCR primer further 59 inthe gM coding sequence.
Thus, we deleted amino acid residues 378–383 (T4), 365–383 (T3),
352–383 (T2) or 337–383 (T1). Each shorter PCR product was
exchanged forthefull-lengthformbydigestingthePCRproductand
gM-eGFP vector with BamHI and XhoI, removing the full-length gM
insert, and ligating the fragments together. Each gM mutant was
thus fused to eGFP at a BamHI restriction site (encoding
glycine+serine). We also made versions of the T2, T3 and T4
truncations in which eGFP was separate to gM, by inserting the self-
complementary oligonucleotide 59-CTAGCTAGCTAGAATTC-
TAGCTAGCTAG-39,whichincludesmultiplestopcodons,intothe
BamHI site, for this purpose blunted with Klenow fragment DNA
polymerase and dephosphorylated with Antarctic alkaline phospha-
tase (New England Biolabs, Hitchin, U.K.). Each construct was
subcloned into the BamHI/SacI sites of the pST76K-SR shuttle
vector using a BglII site in the pEGFP-N3 polylinker and a SacIs i t e
incorporated into the AflII flank primer. Each was then recombined
into the MuHV-4 BAC by standard methods [13]. Where indicated,
we also derived revertant BACs in which the mutant locus was
replaced by the native genomic sequence. Infectious virus was
reconstituted (or not) by transfecting BAC DNA into BHK-21 cells.
Except where indicated, the loxP-flanked BAC/eGFP cassette was
removed from viable viruses by passage through 3T3-CRE cells.
Virus stocks were grown in BHK-21 cells. Infected cells plus
supernatants were freeze-thawed when most cells showed cytopathic
effects (4–5 days post inoculation with 0.001 p.f.u./cell). Cell debris
was pelleted by low-speed centrifugation (10006g, 3 min) and
discarded. Virions were then recovered from supernatants by high
speed centrifugation (38,0006g, 90 min) and stored at 270uC.
Virus titrations
Infectious virus was titered by plaque assay on BHK-21 cells
[38]. Briefly, 10-fold virus dilutions were incubated on cell
monolayers (2 h, 37uC) then overlaid with 0.3% carboxymethyl-
Figure 2. Viral spread visualized by eGFP expression following
BAC DNAtransfection.A. BHK-21 cellsweretransfected withwild-type
orgMtruncationmutant BACDNA.72 h later,infectionwas monitoredby
fluorescence microscopy. Each virus expresses eGFP from an HCMV IE-1
promoter in addition to the eGFP tag on gM. Cells expressing virus-
encoded eGFP appear black. B. Two independent gM-T1 mutants were
compared with their revertants in an experiment similar to A. The images
shown are from 72 h post-transfection. There was also no sign of virus
replication at 6 days post-infection. C. Higher magnification images of
BHK-21 cells after T1.1 and T1.2 BAC transfection showed small clusters of
eGFP
+ fragments. But these were smaller than BHK-21 cells (the scale bar
shows 10 mm), and were presumably non-infectious debris derived from
apoptotic BAC-transfected cells. There was no sign of the neighbouring
BHK-21 cells becoming infected.
doi:10.1371/journal.pone.0002131.g002
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later and stained with 0.1% toluidine blue. Plaques were counted
with a plate microscope. To titer infectious virus in lungs, the lungs
were homogenized in complete medium, then frozen and thawed.
Tissue debris was pelleted by brief centrifugation (10006g, 1 min)
and homogenate supernatants were titered by plaque assay. Latent
virus in spleens was measured by infectious center assay [38]. Single
spleen cell suspensions were cultured on MEF monolayers, again
overlaid with 0.3% carboxymethylcellulose, which were fixed and
stained after 5 days. Pre-formed infectious virus - that forming
plaques after freeze-thawing of the spleen cells - always contributed
,1% of the infectivity recoverable from lymphoid tissue, so the
infectiouscenterassayessentiallymeasured reactivatable latentvirus.
Southern blotting
Viral DNA was extracted by alkaline lysis [38], digested with
restriction endonucleases, electrophoresed through 0.8% agarose
in Tris acetate buffer and transferred to positively charged nylon
membranes (Roche Diagnostics). A
32P-dCTP labelled probe
(APBiotech, Little Chalfont, U.K.) was generated by random
primer extension (Nonaprimer kit, Qbiogene, Bingham, U.K.)
using the BamHI-B genomic clone (49938–59884) as a template
[39]. The membranes were hybridised with the probe (65uC,
18 h), washed to a stringency of 0.2% SSC, 0.1% SDS, and then
exposed to X-ray film.
Immunofluorescence and confocal microscopy
Adherentcells(BHK-21,293T orNIH-3T3)werewashedinPBS,
fixed in 2% paraformaldehyde or 100% methanol, then permeabi-
lized with 0.1% Triton-X100. The MuHV-4 gN was detected with
mAb 3F7 [12], the ORF65 capsid component with mAb MG-12B8
[40] and thymidine kinase with mAb CS-4A5. MAb CS-4A5 was
derived from MuHV-4 carrier mice and identified as thymidine
kinase-specific by staining 293T cells transfected or not with a
MuHV-4 ORF21 expression plasmid. Its specificity was confirmed
by recognizing BHK-21 cells infected with wild-type but not
thymidine kinase-deficient mutants [38]. Bound mAb was detected
with Alexa 568-conjugated goat anti-mouse IgG pAb (Invitrogen
Corporation, Paisley, U.K.). The cells were washed 62i nP B S /
0.1% Tween-20 after each antibody incubation. Nuclei were
counterstained with DAPI. Fluorescence was visualized with an
Olympus IX70 microscope plus a Retiga 2000R camera line
(QImaging) or with a Leica confocal microscope.
Results
Generation of gM C-terminal truncation BAC mutants
We have previously used C-terminal eGFP tagging to visualize
the MuHV-4 gM in infected cells [40–42]. We made 4 gM
truncation mutants with the same eGFP tag. The truncations were
designed to remove progressively a C-terminal acidic cluster (gM-
T4), a distal YXXW motif (gM-T3), an intervening region (gM-T2)
and a proximal YXXW motif (gM-T1) (Fig. 1A). PCR of BAC
DNA, from just upstream of the deletion site to the 59 end of the
eGFP coding sequence, confirmed the predicted size of each gM
cytoplasmic tail (Fig. 1B). The region around the gM locus
(Fig. 1C) was further checked by Southern blot of viral DNA
(Fig. 1D, 1E). Because the T1 truncation mutant failed to
reconstitute infectious virus (see below), we analyzed it as BAC
DNA, comparing 2 independently derived mutants to their
revertants. We also made versions of the FL (full-length), T2, T3
and T4 (truncated) gM-eGFP fusions in which stop codons
separated the gM C-terminus from its eGFP tag (Fig. 1E), so as to
control for any effect of eGFP tagging.
Reconstitution of infectious virus from BAC DNA
After transfecting BAC DNA into BHK-21 cells, the propaga-
tion of the T2, T3 and T4 gM mutants was indistinguishable from
that of the wild-type (Fig. 2A). In contrast, there was no spread of
eGFP signal with either of 2 independently-derived T1 mutants
(Fig. 2B). Nor was there recoverable T1 mutant infectivity by
plaque assay (data not shown). Higher magnification images of
cells transfected with each T1 mutant BAC (Fig. 2C) showed small
clusters of eGFP
+ debris, but no sign of infection spread. Thus, the
distal YXXW motif and the acidic cluster of the gM cytoplasmic
tail were redundant for in vitro MuHV-4 replication, but the tail as
a whole was not.
Viral protein expression by the non-viable gM truncation
mutant
In order to understand why the gM-T1 mutant failed to
produce infectious virus, we examined by immunofluorescence
BHK-21 cells transfected with gM-T1 BAC DNA (Fig. 3). gH/gL,
thymidine kinase and ORF65 (capsid) expression were normal. In
contrast, gN expression - which depends on gM [12] - appeared to
be lower than for the revertant. Since the gM-T1 mutant did not
spread, this analysis was limited by not knowing that that the BAC
DNA taken up by a given cell was intact. Also, as BAC-derived
viruses express eGFP from a Human cytomegalovirus (HCMV)
IE1 promoter [13] independent of endogenous lytic antigens until
the BAC cassette is removed [41,42] (so in Fig. 3A not all the
eGFP
+ cells infected with the revertant BAC express gN) it was
difficult to be sure that eGFP
+ cells transfected with the gM-T1
mutant were really low for gN, or just not supporting lytic
infection.
We were able to address this problem by exploiting the eGFP
tag on gM. In contrast to the mainly nuclear fluorescence of the
free eGFP expressed from the HCMV IE1 promoter, gM-eGFP
fluorescence is mainly perinuclear. Thus, Fig. 3A shows subtle
differences in intracellular eGFP distribution between the gM-T1
(BAC
+gM-eGFP
+) and revertant (BAC
+gM-eGFP
2) BACs, with
the net distribution eGFP fluorescence after gM-T1 BAC
transfection depending on the relative activities of the HCMV
IE1 and gM promoters. In order to identify more precisely the
gM-T1 BAC-transfected cells supporting lytic infection, we fixed
them with methanol rather than paraformaldehyde (Fig. 3B). This
retains membrane-bound eGFP, while free eGFP is washed out, so
detectable eGFP expression is confined to lytic infection. Using
this approach, gN expression by the gM-T1 mutant in eGFP
+
cells, although detectable, was again weak. Thus, the gM-T1 BAC
Figure 3. Viral protein expression by MuHV-4 lacking its gM cytoplasmic tail. A. BHK-21 cells were transfected with gM-T1 mutant BAC
DNA (gM-T1-eGFP) or with the corresponding revertant. 48 h later, the cells were fixed with 2% paraformaldehyde and stained with MuHV-4-specific
mAbs plus Alexa 568-conjugated goat anti-mouse IgG pAb (red). eGFP expression - HCMV IE1-driven eGFP alone for the revertant and HCMV IE1-
driven eGFP+gM-T1-eGFP for the mutant - was visualized directly (green). Nuclei were stained with DAPI (blue). The arrowheads show transfected
cells. B. BHK-21 cells transfected with gM-T1 mutant BAC DNA were fixed instead with 100% methanol. This allowed free eGFP to be washed out,
making eGFP fluorescence more specific to gM-T1 expression. The cells were then stained for gN with mAb 3F7, which works equally well with either
fixation. Representative images are shown. Similar results were obtained in 2 repeat experiments.
doi:10.1371/journal.pone.0002131.g003
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limited gN expression.
Localization of gM-T1-eGFP co-transfected with gN
Since only limited numbers of BHK-21 cells could be
transfected with the 150 kb BAC plasmid, we also examined the
effect of the gM-T1 truncation on gN by co-transfecting the
corresponding expression plasmids into 293T cells (Fig. 4).
Transfected gN could not be identified unless gM was also
transfected (Fig. 4A). As the 3F7 epitope on gN is conformation-
independent [12], this probably reflects poor gN stability rather
than misfolding. Again, gM-T1 co-expression allowed gN
detection, but less well than with the longer forms of gM. Thus,
the results with expression plasmids were consistent with the weak
gN staining after gM-T1 BAC transfection (Fig. 3).
Although each gM truncation could be expressed alone, gN
clearly affected the distribution of gM in co-transfected cells. Thus,
gN expression changed full-length gM-eGFP from a diffusely
perinuclear distribution to one sharply focussed on just one side of
the nucleus (Fig. 4A, 4B). This pattern was consistent with gM/gN
localizing to the trans-Golgi network [12]. It applied also to the
T2, T3 and T4 mutants, but gM-T1, while again perinuclear
without gN, did not appreciably change its distribution when gN
was co-transfected (Fig. 4B). Thus, gN and gM-T1 showed only
limited colocalization, whereas the the other forms of gM co-
localized with gN almost completely. The T1 truncation therefore
appeared to impair the association of gM with gN.
Viral protein expression by the viable gM truncation
mutants
We next looked at viral protein distribution in cells infected with
the viable (T2–T4) gM truncation mutants (Fig. 5). In this context
there was again no sign of gM or gN expression being affected by
the T2–T4 truncations. Nor was the distribution of thymidine
kinase - chosen as a representative tegument protein [43] -
obviously different between the mutant viruses and the wild-type.
The only consistent abnormality of the mutants was a subtle
change in capsid distribution, as revealed by staining for ORF65.
Capsid staining was always predominantly nuclear, but each
truncation mutant showed additional cytoplasmic capsid staining
above that seen with full-length gM.
The predominance of nuclear capsid staining reflects in part
that cytoplasmic capsid transport, secondary envelopment and
virion egress are all rapid [29]. But another important factor is that
capsid antigens are poorly accessible on intact virions because they
are masked by the tegument and glycoproteins. This is especially
true of the MG-12B8 epitope [40]. The cytoplasmic MG-12B8
staining seen with the T2, T3 and T4 gM mutants therefore
suggested that free capsids - or at least capsid components -
accumulated in the cytoplasm. Thus, the immunofluorescence
pictures were consistent a delay in secondary envelopment. The
lack of an obvious difference between the different truncation
mutants implied that this phenotype was due to disruption of the
acidic cluster at the very C-terminus of the gM cytoplasmic tail
(Fig. 1A).
Figure 4. Co-transfection of gM truncation mutants with gN. A. Each gM-eGFP mutant (T1–T4) or the corresponding full-length form (gM-FL-
eGFP) was transfected into 293T cells with or without co-transfected gN. We tested 2 independent gM-T1-eGFP plasmid preparations (1.1, 1.2) to
allow for possible poor transfection efficiency. At 48 h post-transfection, the cells were fixed in 2% paraformaldehyde and stained for gN with mAb
3F7 plus Alexa 568-conjugated goat anti-mouse IgG pAb red). EGFP fluorescence was visualized directly (green). Nuclei were counter-stained with
DAPI (blue). Representative transfected cells are shown. gN was never visible without co-transfected gM. The data are from 1 of 3 equivalent
experiments. B. Higher magnification confocal images made it clear that full-length gM (green) was redistributed when gN (red) was present and that
their distributions co-localized almost completely (yellow). The same is seen for the second shortest gM truncation (gM-T2). In contrast, gM-T1 - here,
for clarity, a cell with atypically high gN expression has been selected - did not obviously change its distribution when gN was supplied, and their co-
localization was much less.
doi:10.1371/journal.pone.0002131.g004
Figure 5. Viral protein distribution in cells infected with viable gM cytoplasmic tail truncation mutants. NIH-3T3 cells were infected with
with full-length (FL) or truncated gM-eGFP virus mutants (T2–T4) as shown (0.3 p.f.u./cell, 18 h), then fixed in 2% paraformaldehyde and stained for
thymidine kinase, gN or the ORF65 capsid component (red). EGFP fluorescence was visualized directly (green). Co-localization is yellow in the merged
image. All these viruses had their BAC-based eGFP expression cassettes removed by loxP recombination, so the only eGFP expressed was that fused
to gM. Nuclei were counter-stained with DAPI (blue). The data are from 1 of 3 equivalent experiments.
doi:10.1371/journal.pone.0002131.g005
MuHV-4 gM
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In order to determine whether this phenotype had marked
functional consequences, we assayed the in vitro lytic replication of
the T2, T3 and T4 mutants after low multiplicity inoculation
(Fig. 6). The truncation mutants showed at most a very minor
replication lag (Fig. 6A). No replication deficit was seen after high
multiplicity infection (Fig. 6B), and low multiplicity infections using
independently derived truncation mutants that lacked eGFP tags
Figure 6. In vitro replication of the viable gM truncation mutants. A. BHK-21 cells were infected with full-length or truncated gM-eGFP viruses
(0.01 p.f.u./cell). After 2 h at 37uC, unattached virus was removed by washing62 in PBS. The virus titres of replicate cultures were then determined by
plaque assay at the times shown. B. BHK-21 cells were infected with the same viruses as in A, but at 5 p.f.u./cell. After 2 h at 37uC, the input virus was
inactivated by acid washing (pH=4 isotonic citrate buffer). Virus titers were then determined by plaque assay at the times shown. C. BHK-21 cells
were infected at low multiplicity as in A, but using the viruses with stop codons separating their gM and eGFP coding sequences. Virus titers were
then determined by plaque assay.
doi:10.1371/journal.pone.0002131.g006
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was no major deficit in in vitro lytic propagation with the T2, T3 or
T4 truncations.
In vivo growth of the viable gM truncation mutants
We then tested the untagged T2, T3 and T4 gM truncation
mutants for in vivo host colonization after intranasal inoculation
(Fig. 7). All the mutants showed a slight deficit in lytic replication
in infected lungs compared to wild-type MuHV-4 (Fig. 7A), but
they showed no deficit compared to the full-length gM control
(which included the same stop codons and downstream eGFP
coding sequence). None of the truncation mutants showed a
reduction in peak latent viral load in the spleen (Fig. 7B). We
concluded that while eGFP tagging may have reduced lytic
infection somewhat, perhaps because the virion tegument would
have to incorporate multiple copies of eGFP, the T2–T4 gM
truncations themselves had little or no effect on host colonization.
Discussion
Our understanding of gamma-herpesvirus lytic functions has
generally lagged behind that of the alpha- and beta-herpesviruses.
This reflects that EBV and KSHV lytic functions are hard to
study, and that the tumours these viruses cause are associated
more with latent than with lytic infection. However, latency has
proved a difficult therapeutic target, because few viral gene
functions are expressed, and it is increasingly realized, particularly
for KSHV [44,45], that lytic and latent infections work together in
host colonization, such that targetting one may help to control the
other [46]. We are therefore using MuHV-4 as a template for
working out how lytic functions contribute to gamma-herpesvirus
replication and pathogenesis. Our aim here was to analyze specific
gM functional domains. The non-viability of gN-deficient MuHV-
4 [11] and the poor expression of gN without gM [12] imply that
the gN-interacting gM extracellular loop [47] is essential. We
therefore targetted another well-defined feature of gM, its
cytoplasmic tail. The distal 31 amino acid residues of the 51
residue tail could be deleted with relative impunity, but while just 4
cytoplasmic tail residues were sufficient for gM expression,
residues 5–20 were also required for function.
gM expressed without gN remained diffusely perinuclear,
consistent with retention in the endoplasmic reticulum, even when
all its cytoplasmic trafficking motifs were intact. Thus, gN is
required for gM to reach its normal site of action in the trans-Golgi
network [29]. This would explain why gN is essential for MuHV-4
replication. gM missing its acidic cluster and distal YXXW motif
(gM-T2) was still re-localized by and co-localized with co-
transfected gN, and replication of the corresponding virus mutant
was accordingly preserved; but when the proximal YXXW motif of
gM was also deleted (gM-T1), the expression of co-transfected gN
was noticeably less, gM was not re-localized and the co-localization
of gM and gN was much reduced. The corresponding mutant virus
also failed to replicate. Thus, it appeared that the gM cytoplasmic
tail is essential for a stable association with gN and therefore for
MuHV-4 replication. gM lacking cytoplasmic trafficking motifs
may not reach the right endoplasmic reticulum micro-domain to
meet up with gN, or a subsequent failure of export may make the
gM/gN complex unstable.
The phenotypes of our MuHV-4 gM mutants were entirely
consistent with a recent in vitro analysis of the HCMV gM [48].
There, the acidic cluster was dispensible, and either the proximal
or distal YxxW motif could be disrupted, but not both. Thus, while
gM is dispensible for the replication of several alpha-herpesviruses,
beta- and gamma-herpesviruses may be similar in their require-
ments for gM and its cytoplasmic tail. The redundancy of gM
cytoplasmic trafficking motifs could possibly reflect an in-built
robustness to maintain virion production despite DNA replication
errors. But this would not explain why gM is so conserved - for
example, gM was found to be identical in 6 otherwise diverse
strains of murine CMV [49]. It seems more likely that single motif
gM mutants have subtle defects that are important for evolution-
ary fitness, where a 10% difference in virus transmissibility would
Figure 7. In vivo replication of the viable gM truncation
mutants. A. C57BL/6 mice were infected intranasally (10
4 p.f.u. in
30 ml) with wild-type (WT) or gM mutant viruses as shown. All these had
their gM and eGFP coding sequences separated by stop codons, so gM
was untagged. The infectious virus titres in lungs were determined by
plaque assay at 5 days post-infection. Each point shows the titre per
organ of one mouse. B. Mice were infected intranasally as in A, and 13
days later titered for splenic virus by infectious centre assay. This is an
assay of reactivatable latent virus, since pre-formed infectious virus is
essentially undetectable in lymphoid tissue after intranasal infection.
Again each point corresponds to the titre per organ of one mouse.
doi:10.1371/journal.pone.0002131.g007
MuHV-4 gM
PLoS ONE | www.plosone.org 9 May 2008 | Volume 3 | Issue 5 | e2131have a major impact, but hard to detect in experimental
pathogenesis, where transmission is hard to reproduce and limits
on animal numbers make replication reductions of ,90% hard to
demonstrate. The apparently dispensibility of gM for the
replication of some alpha-herpesviruses [33,36] may have a
similar explanation: that gM-independent egress pathways make
gM-dependent replication deficits difficult to define experimentally
but still fail to off-set a powerful conservation of gM/gN in natural
infection. The subtle change in capsid distribution with the T2–T4
mutants, and the failure to export a viable gM-T1/gN complex
argued that the MuHV-4 gM cytoplasmic tail has interactions with
the cellular transport machinery that play an important role in
lytic replication.
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